CADTH Reimbursement Review - Patient Input
CF Get Loud has officially submitted our input to the Canadian Agency for Drugs and Technologies in Health (CADTH) on behalf of our CF patient and family community!
CADTH plays an important role in the decision-making process in regards to the public reimbursements of Trikafta.
Thank you to all of the CF patients and family members for their contributions. It is critical that CADTH hears from families that are directly impacted by this disease.
This is a big step in being heard by the federal agency that provides Canada’s decision makers with the evidence they need to make Trikafta accessible to CF patients.
We are proud to share this submission with you.
